Main caricature of Helmy Eltoukhy, who is speaking at HLTH and is Co-founder and CEO at Guardant Health, Inc. Overlay caricature of Helmy Eltoukhy, who is speaking at HLTH and is Co-founder and CEO at Guardant Health, Inc.

Helmy Eltoukhy

Co-founder and CEO

Guardant Health, Inc.


Helmy Eltoukhy, PhD., is a pioneer the biotech industry and Guardant Health’s co-founder and CEO. After receiving his PhD, MS and BS degrees in electrical engineering from Stanford University, he joined the Stanford Genome Technology Center (SGTC) as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies.

During his doctoral studies and at the SGTC, he developed the first semiconductor sequencing platform and first base-calling algorithm for next-generation sequencing under several NHGRI grants. In 2007, he co-founded Avantome to commercialize semiconductor sequencing to help speed up the democratization of high throughput DNA sequencing. At Illumina, Helmy was Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems.